相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B
Mina S. Farag et al.
CLINICAL INFECTIOUS DISEASES (2021)
Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
Stephane Daffis et al.
HEPATOLOGY (2021)
Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
Mark Anderson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
Wai-Kay Seto et al.
GUT (2021)
Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection
Hannah S. J. Choi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Nucleic Acid Polymer Therapy for Hepatitis B Virus: Strong Hepatitis B Surface Antigen Decline But Many Unanswered Questions
Milan J. Sonneveld et al.
GASTROENTEROLOGY (2021)
Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
Oliver E. Amin et al.
HEPATOLOGY (2021)
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Mireia Garcia-Lopez et al.
JOURNAL OF HEPATOLOGY (2021)
Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection
Nina Hensel et al.
NATURE IMMUNOLOGY (2021)
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
Man-Fung Yuen et al.
NATURE MEDICINE (2021)
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
Kimberly Page et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1
Jang-June Park et al.
NATURE COMMUNICATIONS (2021)
The times they are a-changing - A refined proposal for finite HBV nucleos(t)ide analogue therapy
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2021)
Mechanism of Hepatitis B Virus cccDNA Formation
Lei Wei et al.
VIRUSES-BASEL (2021)
Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study
Haiyan Ma et al.
JHEP REPORTS (2021)
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey et al.
HEPATOLOGY (2020)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2020)
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naive to Nucleos(t)ide Therapy
Michel Bazinet et al.
GASTROENTEROLOGY (2020)
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis
Ryan T. Anderson et al.
Clinical Gastroenterology and Hepatology (2020)
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Nina Le Bert et al.
GASTROENTEROLOGY (2020)
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
Yu-Chan Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen supression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment
Edward Gane et al.
JOURNAL OF HEPATOLOGY (2020)
Liver toxicity in the Phase 2 Catalyst 206 trial of Inarigivir 400 mg daily added to a nucleoside in HBV EAg negative patients
Kosh Agarwal et al.
JOURNAL OF HEPATOLOGY (2020)
Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2020)
Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection
Scott Fung et al.
JOURNAL OF HEPATOLOGY (2020)
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
Edward Gane et al.
JOURNAL OF HEPATOLOGY (2020)
Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial
Florian van Bömmel et al.
JOURNAL OF HEPATOLOGY (2020)
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
Stylianos Bournazos et al.
NATURE (2020)
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Carolina Boni et al.
GASTROENTEROLOGY (2019)
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang et al.
HEPATOLOGY INTERNATIONAL (2019)
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients
Alessandro Loglio et al.
JOURNAL OF HEPATOLOGY (2019)
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study
Edward Gane et al.
JOURNAL OF HEPATOLOGY (2019)
Epigenetic signature of PD-1+TCF1+CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade
Rohit R. Jadhav et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection
Anna D. Kosinska et al.
SCIENTIFIC REPORTS (2019)
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2019)
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
Kin Seng Liem et al.
GUT (2019)
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
Yee Hui Yeo et al.
GASTROENTEROLOGY (2019)
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+T cells in chronically HBV-infected patients with low viral load
Anita Schuch et al.
GUT (2019)
The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation Among Asian Patients With Chronic Hepatitis B: A Systematic Review
Jiaye Liu et al.
HEPATOLOGY (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
Kali Zhou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
S. Van Hees et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2018)
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
Wen-Juei Jeng et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients
Jing Wang et al.
JOURNAL OF HEPATOLOGY (2018)
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
Harry L. A. Janssen et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
Franziska Rinker et al.
JOURNAL OF HEPATOLOGY (2018)
Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines
Suzanne Faure-Dupuy et al.
JOURNAL OF INNATE IMMUNITY (2018)
Natural history of serum HBV-RNA in chronic HBV infection
J. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients
C. -H. Chen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection
Loghman Salimzadeh et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Alice R. Burton et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2017)
Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t) ide Analogue: A Randomized, Controlled Trial (PEGON)
Heng Chi et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
Paola Fisicaro et al.
NATURE MEDICINE (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro
Jan Martin Berke et al.
ANTIVIRAL RESEARCH (2017)
New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies
Adam J. Gehring
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial
Marc Bourliere et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study
J. Ahn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
William S. Mason et al.
GASTROENTEROLOGY (2016)
Interferon-gamma and Tumor Necrosis Factor-alpha Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis
Yuchen Xia et al.
GASTROENTEROLOGY (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination
Danming Zhu et al.
JOURNAL OF IMMUNOLOGY (2016)
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host
Anna Schurich et al.
Cell Reports (2016)
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
T. -C. Tseng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
Seiichi Sato et al.
IMMUNITY (2015)
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J. Gane et al.
JOURNAL OF HEPATOLOGY (2015)
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
Stephan Menne et al.
JOURNAL OF HEPATOLOGY (2015)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
W. -K. Seto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Josh Crouse et al.
IMMUNITY (2014)
Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
Wai-Kay Seto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Restoration of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
Bertram Bengsch et al.
JOURNAL OF HEPATOLOGY (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials
Stefania Capone et al.
EXPERT REVIEW OF VACCINES (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
Response-Guided Peginterferon Therapy in Hepatitis B e Antigen-Positive Chronic Hepatitis B Using Serum Hepatitis B Surface Antigen Levels
Milan J. Sonneveld et al.
HEPATOLOGY (2013)
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
Dao-Zhen Xu et al.
JOURNAL OF HEPATOLOGY (2013)
T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
Daniel T. Utzschneider et al.
NATURE IMMUNOLOGY (2013)
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+T cells and successful immunotherapy against chronic viral liver infection
Li-Rung Huang et al.
NATURE IMMUNOLOGY (2013)
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2012)
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2012)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B
Zeng Minde et al.
LIVER INTERNATIONAL (2012)
The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication
Gaetan Billioud et al.
ANTIVIRAL RESEARCH (2011)
Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
Roeland Zoutendijk et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Paola Fisicaro et al.
GASTROENTEROLOGY (2010)
Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-up Study
Jessica Liu et al.
GASTROENTEROLOGY (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers: Disease Phase Influences Correlation with Viral Load and Intrahepatic Hepatitis B Virus Markers
Alexander J. V. Thompson et al.
HEPATOLOGY (2010)
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
Jerzy Jaroszewicz et al.
JOURNAL OF HEPATOLOGY (2010)
CD8(+) T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions
Sandra Phillips et al.
JOURNAL OF IMMUNOLOGY (2010)
Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAs
Thomas J. Cradick et al.
MOLECULAR THERAPY (2010)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection
Shinichi Asabe et al.
JOURNAL OF VIROLOGY (2009)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
Fen-Yu Ren et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study
S-H Yang et al.
GENE THERAPY (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Platelets mediate cytotoxic T lymphocyte-induced liver damage
M Iannacone et al.
NATURE MEDICINE (2005)
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
M Isogawa et al.
JOURNAL OF VIROLOGY (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor
PCN Rensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
C Boni et al.
JOURNAL OF HEPATOLOGY (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection
R Thimme et al.
JOURNAL OF VIROLOGY (2003)
Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes
G Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice
LG Guidotti et al.
JOURNAL OF VIROLOGY (2002)
Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes
K Kakimi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice
SF Wieland et al.
JOURNAL OF VIROLOGY (2000)
分享论文
